NRX Pharmaceuticals NRXP
NASDAQ NRXP
$2.85 -0.07 (-2.40%)
At close: Oct 1, 2026 · 4:00 PM EDT

NRX Pharmaceuticals (NRXP) Operating Expenses (2017 - 2026)

Updated

NRX Pharmaceuticals' Operating Expenses was $7.61 million in Q2 2026, up 103.9% from $3.73 million a year earlier and up 30.9% from the prior quarter.

Analysis

NRX Pharmaceuticals (NRXP) Operating Expenses (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, NRX Pharmaceuticals' Operating Expenses was $23.29 million through Jun 30, 2026, up 78.7% year-over-year; for FY2025, it was $17.45 million, down 5.7% from FY2024.

  • Operating Expenses has now declined for four consecutive years, with a five-year compound annual growth rate of -19.4% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $18.5 million in FY2024 (-33.5%), $27.84 million in FY2023 (-37.2%), $44.34 million in FY2022 (-61.7%) and $115.8 million in FY2021 (+125.3%).
  • The Q2 2026 figure marks the highest quarterly Operating Expenses since Q2 2023.
  • Compared with a year earlier, Operating Expenses has increased for four straight quarters, with growth averaging 18.9% over the last eight quarters.
  • The best year-over-year quarter for Operating Expenses over five years was Q3 2021 (growth of 290.3%); the worst was Q4 2022 (a decline of 81.3%).
  • Per Business Quant data, NRXP's Operating Expenses in the three quarters before Q2 2026 was $5.81 million (Q1 2026), $5.61 million (Q4 2025) and $4.27 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.12 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.56 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -9.70 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 18.20 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 2.09 Bn
10 NRX Pharmaceuticals 126.02 Mn 77.61 Mn 426,000.00 7.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.61 Mn
Mar 31, 2026 5.81 Mn
Dec 31, 2025 5.61 Mn
Sep 30, 2025 4.27 Mn
Jun 30, 2025 3.73 Mn
Mar 31, 2025 3.85 Mn
Dec 31, 2024 2.43 Mn
Sep 30, 2024 3.02 Mn
Jun 30, 2024 7.05 Mn
Mar 31, 2024 6.00 Mn
Dec 31, 2023 4.41 Mn
Sep 30, 2023 5.81 Mn
Jun 30, 2023 8.19 Mn
Mar 31, 2023 3.85 Mn
Dec 31, 2022 9.89 Mn
Sep 30, 2022 9.14 Mn
Jun 30, 2022 9.60 Mn
Mar 31, 2022 15.71 Mn
Dec 31, 2021 52.98 Mn
Sep 30, 2021 20.10 Mn
API Access

NRX Pharmaceuticals Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=NRXP&period=max&api_key=YOUR_API_KEY